Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Mr p how was the the webinar? I’m thinking about adding here.
SMIN. Surprise change in CEO. Sales, profits, margins and cash generation all look OK. Dividend up 5% and a share buy-back programme. No need to worry here; will come back if the webcast has anything noteworthy in it.
Certainly moving back to the 'top-up zone' now...
I have been tracking this share for awhile. I am ready to make a purchase because I think their prospects are good but the share price seems to be falling and I don't understand why? Does anyone else have an insight as to why this is the case.
Thanks for the summary. Market seems to be saying 'boring' too! ;)
I joined the on-line presentation given by Paul Keel and Clare Scherrer following the results which were a tad better than expected. Sales, margins, ROCE and cash conversion all up, a strong balance sheet and progress on ESG but somehow.......boring! Claire was clear that the deployment of the capital generated was to the business first and shareholder second. The dividend was raised a slightly miserly 5.1% and the share buy back programme from the sale of medical is complete.
Guidance for FY24 is revenue plus 4-6% and an improvement in margins. We we directed to this coming more in the second half (how often have i heard that!) partly because of the business cycle at Smiths Interconnect and the higher margins on maintenance than OE at Smiths Detection which should be coming through later. Claire would not commit to 100% cash conversion but said there should be an improvement on this year's 86%.
All in all most satisfactory, however I experienced a smugness about the results from Paul which I don't think they merited.
Plenty of recent Director Buys and absence of silly comments on here have persuaded me to venture into the unknown.
Nice RNS
get in ,looking good
No, you had to buy them before the ex dividend date
Hi, I purchased some Smiths shares yesterday. Will I be eligible for a dividend as the 7th is the ex div date?
On 11 November 2021, Smiths Group plc ("Smiths Group") announced its intention to commence a share repurchase programme of Smith Group's ordinary shares (the "Ordinary Shares") up to a maximum consideration of £742 million (the "Programme"). The purpose of the Programme is to reduce the share capital of Smiths Group. The effect of the reduction in share capital will be to return 55% of the initial cash proceeds from the sale of Smiths Medical to shareholders.
Paultp yes I do from rns
The first tranche of the Programme will commence on 19 November 2021 and is expected to end by no later than 18 March 2022
Smith & Nephew PLC said Thursday that it is targeting 4%-6% consistent organic revenue growth by 2024 and set a new commitment to return surplus capital to shareholders through regular share buybacks.
The U.K. medical-technology company said that it expects to buy back between $250 million and $300 million of shares next year.
S&N said it plans to maintain higher investment in innovation to drive organic growth and continue buying new technologies, while expanding in higher growth segments.
Anyone have any clue about the time it will take to complete this share buy back?
Everyone, I got the link from another board who triggered a petition against shorting
You may be interested to sign it as well so please circulate to all boards you are on and they are affected
https://www.change.org/p/department-for-business-energy-industrial-strategy-make-short-selling-of-shares-illegal
Got in at 1396 div 2mr sweet
New Low today (YTD) . What's going on ?
Smiths Group has found a buyer, ICU Medical, prepared to pay $0.4B more for the Medical division, plus a $0.1B earn out.
Market seemed to like the news and if it hadn’t been a red day all round this would have closed up 5%.
recent director buying not far from current levels, i see value here. and certainly worth adding to on any weakness below 14 quid.
It looks like SGE are committed to buying around 10% of their shares back.
ULVR and BAE around 3%.
According to today’s RNS there will be a £715M share buy back programme. That’s just over 12% of the mcap.
Be interesting to see how that figure compares with recent buy backs on the FTSE 100 eg SGE, ULVR, BAE…
Very low price and large buys at end of last few days. Some one is topping up for a divi?
They haven't announced how much as the completion is not yet done. I guess we have to wait for few months until they see all the paper work and cash in.